{
  "DOI": "10.1038/ejhg.2009.238",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2009.238",
  "alternative-id": [
    "BFejhg2009238"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Xu",
      "given": "Mingqing",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Li",
      "given": "Sheng",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Xing",
      "given": "Qinghe",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gao",
      "given": "Rui",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Feng",
      "given": "Guoyin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lin",
      "given": "Zhiguang",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "St Clair",
      "given": "David",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "He",
      "given": "Lin",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2010,
        1,
        20
      ]
    ],
    "date-time": "2010-01-20T11:25:05Z",
    "timestamp": 1263986705000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T16:58:44Z",
    "timestamp": 1684429124000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        27
      ]
    ],
    "date-time": "2024-03-27T16:36:00Z",
    "timestamp": 1711557360171
  },
  "is-referenced-by-count": 28,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "6",
  "issued": {
    "date-parts": [
      [
        2010,
        1,
        20
      ]
    ]
  },
  "journal-issue": {
    "issue": "6",
    "published-print": {
      "date-parts": [
        [
          2010,
          6
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2010,
            1,
            20
          ]
        ],
        "date-time": "2010-01-20T00:00:00Z",
        "timestamp": 1263945600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2009238.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2009238",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2009238.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "707-712",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2010,
        1,
        20
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2010,
        1,
        20
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2010,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1056/NEJMoa002028",
      "author": "JG Csernansky",
      "doi-asserted-by": "publisher",
      "first-page": "16",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2009238_CR1",
      "unstructured": "Csernansky JG, Mahmoud R, Brenner R : Risperidone-USA-79 Study Group. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med 2002; 346: 16–22.",
      "volume": "346",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0140-6736(08)61764-X",
      "author": "S Leucht",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "journal-title": "Lancet",
      "key": "BFejhg2009238_CR2",
      "unstructured": "Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM : Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009; 373: 31–41.",
      "volume": "373",
      "year": "2009"
    },
    {
      "DOI": "10.1097/01.jcp.0000203196.65710.2b",
      "author": "HY Lane",
      "doi-asserted-by": "publisher",
      "first-page": "128",
      "journal-title": "J Clin Psychopharmacol",
      "key": "BFejhg2009238_CR3",
      "unstructured": "Lane HY, Liu YC, Huang CL et al: Risperidone-related weight gain: genetic and nongenetic predictors. J Clin Psychopharmacol 2006; 26: 128–134.",
      "volume": "26",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.amjmed.2007.02.005",
      "author": "TS Stroup",
      "doi-asserted-by": "publisher",
      "first-page": "S26",
      "issue": "4 Suppl 1",
      "journal-title": "Am J Med",
      "key": "BFejhg2009238_CR4",
      "unstructured": "Stroup TS : Heterogeneity of treatment effects in schizophrenia. Am J Med 2007; 120 (4 Suppl 1): S26–S31.",
      "volume": "120",
      "year": "2007"
    },
    {
      "DOI": "10.2217/14622416.7.7.987",
      "author": "Q Xing",
      "doi-asserted-by": "publisher",
      "first-page": "987",
      "journal-title": "Pharmacogenomics",
      "key": "BFejhg2009238_CR5",
      "unstructured": "Xing Q, Gao R, Li H et al: Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients. Pharmacogenomics 2006; 7: 987–993.",
      "volume": "7",
      "year": "2006"
    },
    {
      "DOI": "10.1017/S146114570600719X",
      "author": "Q Xing",
      "doi-asserted-by": "publisher",
      "first-page": "631",
      "journal-title": "Int J Neuropsychopharmacol",
      "key": "BFejhg2009238_CR6",
      "unstructured": "Xing Q, Qian X, Li H et al: The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients. Int J Neuropsychopharmacol 2007; 10: 631–637.",
      "volume": "10",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.neulet.2006.09.014",
      "author": "L Wang",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Neurosci Lett",
      "key": "BFejhg2009238_CR7",
      "unstructured": "Wang L, Yu L, He G et al: Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients. Neurosci Lett 2007; 414: 1–4.",
      "volume": "414",
      "year": "2007"
    },
    {
      "DOI": "10.2217/14622416.8.10.1337",
      "author": "A Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "1337",
      "journal-title": "Pharmacogenomics",
      "key": "BFejhg2009238_CR8",
      "unstructured": "Zhang A, Xing Q, Wang L et al: Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study. Pharmacogenomics 2007; 8: 1337–1345.",
      "volume": "8",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.npp.1301418",
      "author": "J Xuan",
      "doi-asserted-by": "publisher",
      "first-page": "305",
      "journal-title": "Neuropsychopharmacology",
      "key": "BFejhg2009238_CR9",
      "unstructured": "Xuan J, Zhao X, He G et al: Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study. Neuropsychopharmacology 2008; 33: 305–311.",
      "volume": "33",
      "year": "2008"
    },
    {
      "DOI": "10.1097/FPC.0b013e32830500e2",
      "author": "B Gu",
      "doi-asserted-by": "publisher",
      "first-page": "721",
      "journal-title": "Pharmacogenet Genomics",
      "key": "BFejhg2009238_CR10",
      "unstructured": "Gu B, Wang L, Zhang AP et al: Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patients. Pharmacogenet Genomics 2008; 18: 721–727.",
      "volume": "18",
      "year": "2008"
    },
    {
      "DOI": "10.1038/sj.npp.1301619",
      "author": "XY Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "2200",
      "journal-title": "Neuropsychopharmacology",
      "key": "BFejhg2009238_CR11",
      "unstructured": "Zhang XY, Zhou DF, Wu GY et al: BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia. Neuropsychopharmacology 2008; 33: 2200–2205.",
      "volume": "33",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0006-8993(02)03215-8",
      "author": "J Chlan-Fourney",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "Brain Res",
      "key": "BFejhg2009238_CR12",
      "unstructured": "Chlan-Fourney J, Ashe P, Nylen K, Juorio AV, Li XM : Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration. Brain Res 2002; 954: 11–20.",
      "volume": "954",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.schres.2005.11.021",
      "author": "A Pillai",
      "doi-asserted-by": "publisher",
      "first-page": "95",
      "journal-title": "Schizophr Res",
      "key": "BFejhg2009238_CR13",
      "unstructured": "Pillai A, Terry Jr AV, Mahadik SP : Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophr Res 2006; 82: 95–106.",
      "volume": "82",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.jpsychires.2006.08.007",
      "author": "XY Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "997",
      "journal-title": "J Psychiatr Res",
      "key": "BFejhg2009238_CR14",
      "unstructured": "Zhang XY, Tan YL, Zhou DF et al: Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. J Psychiatr Res 2007; 41: 997–1004.",
      "volume": "41",
      "year": "2007"
    },
    {
      "DOI": "10.1080/15622970802182733",
      "author": "EN Rizos",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "World J Biol Psychiatry",
      "key": "BFejhg2009238_CR15",
      "unstructured": "Rizos EN, Papadopoulou A, Laskos E et al: Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. World J Biol Psychiatry 2008; 10: 1–5.",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1159/000205518",
      "author": "BH Lee",
      "doi-asserted-by": "publisher",
      "first-page": "51",
      "journal-title": "Neuropsychobiology",
      "key": "BFejhg2009238_CR16",
      "unstructured": "Lee BH, Kim YK : Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment. Neuropsychobiology 2009; 59: 51–58.",
      "volume": "59",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S0092-8674(03)00035-7",
      "author": "MF Egan",
      "doi-asserted-by": "publisher",
      "first-page": "257",
      "journal-title": "Cell",
      "key": "BFejhg2009238_CR17",
      "unstructured": "Egan MF, Kojima M, Callicott JH et al: The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257–269.",
      "volume": "112",
      "year": "2003"
    },
    {
      "DOI": "10.1097/FPC.0b013e3282f85e26",
      "author": "MQ Xu",
      "doi-asserted-by": "publisher",
      "first-page": "449",
      "journal-title": "Pharmacogenet Genomics",
      "key": "BFejhg2009238_CR18",
      "unstructured": "Xu MQ, St Clair D, Feng GY et al: BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced extrapyramidal syndrome in the Chinese population. Pharmacogenet Genomics 2008; 18: 449–457.",
      "volume": "18",
      "year": "2008"
    },
    {
      "DOI": "10.1038/sj.mp.4000749",
      "author": "MO Krebs",
      "doi-asserted-by": "publisher",
      "first-page": "558",
      "journal-title": "Mol Psychiatry",
      "key": "BFejhg2009238_CR19",
      "unstructured": "Krebs MO, Guillin O, Bourdell MC et al: Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol Psychiatry 2000; 5: 558–562.",
      "volume": "5",
      "year": "2000"
    },
    {
      "DOI": "10.1016/S0304-3940(03)00828-0",
      "author": "CJ Hong",
      "doi-asserted-by": "publisher",
      "first-page": "206",
      "journal-title": "Neurosci Lett",
      "key": "BFejhg2009238_CR20",
      "unstructured": "Hong CJ, Yu YW, Lin CH, Tsai SJ : An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 2003; 349: 206–208.",
      "volume": "349",
      "year": "2003"
    },
    {
      "DOI": "10.1385/NMM:5:3:243",
      "author": "YJ Liou",
      "doi-asserted-by": "publisher",
      "first-page": "243",
      "journal-title": "Neuromolecular Med",
      "key": "BFejhg2009238_CR21",
      "unstructured": "Liou YJ, Liao DL, Chen JY et al: Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients. Neuromolecular Med 2004; 5: 243–251.",
      "volume": "5",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s00702-004-0233-9",
      "author": "S Anttila",
      "doi-asserted-by": "publisher",
      "first-page": "885",
      "journal-title": "J Neural Transm",
      "key": "BFejhg2009238_CR22",
      "unstructured": "Anttila S, Illi A, Kampman O, Mattila KM, Lehtimäki T, Leinonen E : Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics. J Neural Transm 2005; 112: 885–890.",
      "volume": "112",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.schres.2006.12.008",
      "author": "MQ Xu",
      "doi-asserted-by": "publisher",
      "first-page": "6",
      "journal-title": "Schizophr Res",
      "key": "BFejhg2009238_CR23",
      "unstructured": "Xu MQ, St Clair D, Ott J, Feng GY, He L : Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr Res 2007; 91: 6–13.",
      "volume": "91",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ajmg.b.30619",
      "author": "HM Chao",
      "doi-asserted-by": "publisher",
      "first-page": "505",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "BFejhg2009238_CR24",
      "unstructured": "Chao HM, Kao HT, Porton B : BDNF Val66Met variant and age of onset in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2008; 147: 505–506.",
      "volume": "147",
      "year": "2008"
    },
    {
      "DOI": "10.1038/sj.npp.1301619",
      "author": "XY Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "2200",
      "journal-title": "Neuropsychopharmacology",
      "key": "BFejhg2009238_CR25",
      "unstructured": "Zhang XY, Zhou DF, Wu GY et al: BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia. Neuropsychopharmacology 2008; 33: 2200–2205.",
      "volume": "33",
      "year": "2008"
    },
    {
      "DOI": "10.1176/appi.ajp.2007.05111903",
      "author": "BC Ho",
      "doi-asserted-by": "publisher",
      "first-page": "1890",
      "journal-title": "Am J Psychiatry",
      "key": "BFejhg2009238_CR26",
      "unstructured": "Ho BC, Andreasen NC, Dawson JD, Wassink TH : Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry 2007; 164: 1890–1899.",
      "volume": "164",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.pnpbp.2008.05.016",
      "author": "SG Kang",
      "doi-asserted-by": "publisher",
      "first-page": "1545",
      "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry",
      "key": "BFejhg2009238_CR27",
      "unstructured": "Kang SG, Choi JE, An H et al: No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1545–1548.",
      "volume": "32",
      "year": "2008"
    },
    {
      "DOI": "10.2217/14622416.9.11.1589",
      "author": "JK Rybakowski",
      "doi-asserted-by": "publisher",
      "first-page": "1589",
      "journal-title": "Pharmacogenomics",
      "key": "BFejhg2009238_CR28",
      "unstructured": "Rybakowski JK : BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics 2008; 9: 1589–1593.",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.2466/pr0.1962.10.3.799",
      "author": "JE Overall",
      "doi-asserted-by": "publisher",
      "first-page": "799",
      "journal-title": "Psychol Rep",
      "key": "BFejhg2009238_CR29",
      "unstructured": "Overall JE, Gorham DR : The brief psychiatric rating scale. Psychol Rep 1962; 10: 799–812.",
      "volume": "10",
      "year": "1962"
    },
    {
      "DOI": "10.1016/S0165-1781(99)00114-6",
      "author": "D Lachar",
      "doi-asserted-by": "publisher",
      "first-page": "259",
      "journal-title": "Psychiatry Res",
      "key": "BFejhg2009238_CR30",
      "unstructured": "Lachar D, Bailley SE, Rhoades HM, Varner RV : Use of BPRS-A percent change scores to identify significant clinical improvement: accuracy of treatment response classification in acute psychiatric inpatients. Psychiatry Res 1999; 89: 259–268.",
      "volume": "89",
      "year": "1999"
    },
    {
      "DOI": "10.1016/j.biopsych.2007.04.043",
      "author": "S Kumra",
      "doi-asserted-by": "publisher",
      "first-page": "524",
      "journal-title": "Biol Psychiatry",
      "key": "BFejhg2009238_CR31",
      "unstructured": "Kumra S, Kranzler H, Gerbino-Rosen G et al: Clozapine and ‘high-dose’ olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison. Biol Psychiatry 2008; 63: 524–529.",
      "volume": "63",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0924-977X(03)00006-3",
      "author": "G Zalsman",
      "doi-asserted-by": "publisher",
      "first-page": "183",
      "journal-title": "Eur Neuropsychopharmacol",
      "key": "BFejhg2009238_CR32",
      "unstructured": "Zalsman G, Frisch A, Lev-Ran S et al: DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study. Eur Neuropsychopharmacol 2003; 13: 183–185.",
      "volume": "13",
      "year": "2003"
    },
    {
      "DOI": "10.1111/j.1440-1819.2007.01633.x",
      "author": "N Sakumoto",
      "doi-asserted-by": "publisher",
      "first-page": "174",
      "journal-title": "Psychiatry Clin Neurosci",
      "key": "BFejhg2009238_CR33",
      "unstructured": "Sakumoto N, Kondo T, Mihara K, Suzuki A, Yasui-Furukori N : Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia. Psychiatry Clin Neurosci 2007; 61: 174–180.",
      "volume": "61",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S1570-0232(02)00661-X",
      "author": "A LLerena",
      "doi-asserted-by": "publisher",
      "first-page": "213",
      "journal-title": "J Chromatogr B Analyt Technol Biomed Life Sci",
      "key": "BFejhg2009238_CR34",
      "unstructured": "LLerena A, Berecz R, Dorado P et al: Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 783: 213–219.",
      "volume": "783",
      "year": "2003"
    },
    {
      "DOI": "10.1093/bioinformatics/bth457",
      "author": "JC Barrett",
      "doi-asserted-by": "publisher",
      "first-page": "263",
      "journal-title": "Bioinformatics",
      "key": "BFejhg2009238_CR35",
      "unstructured": "Barrett JC, Fry B, Maller J, Daly MJ : Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265.",
      "volume": "21",
      "year": "2005"
    },
    {
      "DOI": "10.1086/319501",
      "author": "M Stephens",
      "doi-asserted-by": "publisher",
      "first-page": "978",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2009238_CR36",
      "unstructured": "Stephens M, Smith NJ, Donnelly P : A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978–989.",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.3758/BF03203630",
      "author": "E Erdfelder",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Behav Res Methods Instrum Comput",
      "key": "BFejhg2009238_CR37",
      "unstructured": "Erdfelder E, Faul F, Buchner A : *Power: a general power analysis program. Behav Res Methods Instrum Comput 1996; 28: 1–11.",
      "volume": "28",
      "year": "1996"
    },
    {
      "DOI": "10.1086/424390",
      "author": "T Becker",
      "doi-asserted-by": "publisher",
      "first-page": "561",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2009238_CR38",
      "unstructured": "Becker T, Knapp M : A powerful strategy to account for multiple testing in the context of haplotype analysis. Am J Hum Genet 2004; 75: 561–570.",
      "volume": "75",
      "year": "2004"
    },
    {
      "DOI": "10.1038/clpt.2009.2",
      "author": "A Gomez",
      "doi-asserted-by": "publisher",
      "first-page": "426",
      "journal-title": "Clin Pharmacol Ther",
      "key": "BFejhg2009238_CR39",
      "unstructured": "Gomez A, Ingelman-Sundberg M : Pharmacoepigenetics: its role in interindividual differences in drug response. Clin Pharmacol Ther 2009; 85: 426–430.",
      "volume": "85",
      "year": "2009"
    },
    {
      "DOI": "10.1038/35075076",
      "author": "O Guillin",
      "doi-asserted-by": "publisher",
      "first-page": "86",
      "journal-title": "Nature",
      "key": "BFejhg2009238_CR40",
      "unstructured": "Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P : BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 2001; 411: 86–89.",
      "volume": "411",
      "year": "2001"
    },
    {
      "DOI": "10.1038/sj.npp.1301571",
      "author": "K Martinowich",
      "doi-asserted-by": "publisher",
      "first-page": "73",
      "journal-title": "Neuropsychopharmacology",
      "key": "BFejhg2009238_CR41",
      "unstructured": "Martinowich K, Lu B : Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2008; 33: 73–83.",
      "volume": "33",
      "year": "2008"
    },
    {
      "DOI": "10.1097/01.wnr.0000175245.58708.6b",
      "author": "D Gourion",
      "doi-asserted-by": "publisher",
      "first-page": "1407",
      "journal-title": "Neuroreport",
      "key": "BFejhg2009238_CR42",
      "unstructured": "Gourion D, Goldberger C, Leroy S, Bourdel MC, Olié JP, Krebs MO : Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport 2005; 16: 1407–1410.",
      "volume": "16",
      "year": "2005"
    }
  ],
  "reference-count": 42,
  "references-count": 42,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2009238"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study"
  ],
  "type": "journal-article",
  "volume": "18"
}